Why Japan continues to be a land for optimism

It used to be fashionable to criticize Japan for its stagnant economic growth, falling and aging demographics and insular culture, among others, which had resulted in its declining significance in the global economy and geopolitics.

Back in 1998, the media even coined the phrase “Japan Passing,” when then-U.S. President Bill Clinton visited China and bypassed Japan, which came to be viewed as a sign of the nation’s slide into irrelevance on the global stage.

Japan Passing was particularly pressing from the 1990s, following the collapse of the bubble economy, a series of financial crises after that and stubborn deflation and the “lost decades,” accentuated by a passive and timid foreign policy of “checkbook diplomacy” from the First Gulf War onward.

Japan income fundJPMorgan Japan Small Cap Growth & Income (LONJSGI), targets Japan income without compromising on Japanese growth opportunities. This Japan income investing opportunity gives investors access to a diverse and fast growing sector managed by local managers.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
Twitter
LinkedIn
JPMorgan Japan Small Cap Growth & Income

More articles like this

JPMorgan Japan Small Cap Growth & Income

Japan economy grows 0.4% in Q4, avoids recession

Japan’s economy expanded at an annualized clip of 0.4% in October to December from the previous quarter, better than the initial estimate for a 0.4% contraction, government data showed on Monday. The revised figure for gross

JPMorgan Japan Small Cap Growth & Income

Japan ISA investing for tax-free growth and income

Investing in Japan is the hot investment topic with Japan’s equity market Nikkei stock average topping the 40,000 mark for the first time on 4 March 2024. DirectorsTalk caught up with Alexa Henderson, Non-executive chairman of JPMorgan

JPMorgan Japan Small Cap Growth & Income

Japan’s Nikkei hits second consecutive record high

Japan’s Nikkei share average scaled record highs for the second consecutive session, supported by upbeat performances in pharmaceuticals, although profit-taking capped some of those gains. The Nikkei ended 0.35% higher at a new closing high of 39,233.71.